La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies

Identifieur interne : 001685 ( Main/Exploration ); précédent : 001684; suivant : 001686

Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies

Auteurs : Junchao Tong [Canada] ; Isabelle Boileau [Canada] ; Yoshiaki Furukawa [Japon] ; Li-Jan Chang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Stephen J. Kish [Canada]

Source :

RBID : PMC:3208151

Abstract

The choice of reference region in positron emission tomography (PET) human brain imaging of the vesicular monoamine transporter 2 (VMAT2), a marker of striatal dopamine innervation, has been arbitrary, with cerebellar, whole cerebral, frontal, or occipital cortices used. To establish whether levels of VMAT2 are in fact low in these cortical areas, we measured VMAT2 protein distribution by quantitative immunoblotting in autopsied normal human brain (n=6). Four or five species of VMAT2 immunoreactivity (75, 55, 52, 45, 35 kDa) were detected, which were all markedly reduced in intensity in nigrostriatal regions of patients with parkinsonian conditions versus matched controls (n=9 to 10 each). Using the intact VMAT2 immunoreactivity, cerebellar and cerebral neocortices had levels of the transporter >100-fold lower than the VMAT2-rich striatum and with no significant differences among the cortical regions. We conclude that human cerebellar and cerebral cortices contain negligible VMAT2 protein versus the striatum and, in this respect, all satisfy a criterion for a useful reference region for VMAT2 imaging. The slightly lower PET signal for VMAT2 binding in occipital (the currently preferred reference region) versus cerebellar cortex might not therefore be explained by differences in VMAT2 protein itself but possibly by other imaging variables, for example, partial volume effects.


Url:
DOI: 10.1038/jcbfm.2011.63
PubMed: 21522164
PubMed Central: 3208151


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies</title>
<author>
<name sortKey="Tong, Junchao" sort="Tong, Junchao" uniqKey="Tong J" first="Junchao" last="Tong">Junchao Tong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Boileau, Isabelle" sort="Boileau, Isabelle" uniqKey="Boileau I" first="Isabelle" last="Boileau">Isabelle Boileau</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, Faculty of Medicine, University and Post Graduate University of Juntendo</institution>
, Tokyo,
<country>Japan</country>
</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chang, Li Jan" sort="Chang, Li Jan" uniqKey="Chang L" first="Li-Jan" last="Chang">Li-Jan Chang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A" last="Wilson">Alan A. Wilson</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J" last="Kish">Stephen J. Kish</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21522164</idno>
<idno type="pmc">3208151</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208151</idno>
<idno type="RBID">PMC:3208151</idno>
<idno type="doi">10.1038/jcbfm.2011.63</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000009</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000009</idno>
<idno type="wicri:Area/Pmc/Curation">000009</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000009</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000965</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000965</idno>
<idno type="wicri:Area/Ncbi/Merge">000E68</idno>
<idno type="wicri:Area/Ncbi/Curation">000E68</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E68</idno>
<idno type="wicri:doubleKey">0271-678X:2011:Tong J:distribution:of:vesicular</idno>
<idno type="wicri:Area/Main/Merge">001757</idno>
<idno type="wicri:Area/Main/Curation">001685</idno>
<idno type="wicri:Area/Main/Exploration">001685</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies</title>
<author>
<name sortKey="Tong, Junchao" sort="Tong, Junchao" uniqKey="Tong J" first="Junchao" last="Tong">Junchao Tong</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Boileau, Isabelle" sort="Boileau, Isabelle" uniqKey="Boileau I" first="Isabelle" last="Boileau">Isabelle Boileau</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, Faculty of Medicine, University and Post Graduate University of Juntendo</institution>
, Tokyo,
<country>Japan</country>
</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chang, Li Jan" sort="Chang, Li Jan" uniqKey="Chang L" first="Li-Jan" last="Chang">Li-Jan Chang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A" last="Wilson">Alan A. Wilson</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J" last="Kish">Stephen J. Kish</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Human Brain Laboratory, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Addiction Imaging Research Group, Vivian M Rakoff PET Centre, Centre for Addiction and Mental Health</institution>
, Toronto, Ontario,
<country>Canada</country>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Cerebral Blood Flow & Metabolism</title>
<idno type="ISSN">0271-678X</idno>
<idno type="eISSN">1559-7016</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The choice of reference region in positron emission tomography (PET) human brain imaging of the vesicular monoamine transporter 2 (VMAT2), a marker of striatal dopamine innervation, has been arbitrary, with cerebellar, whole cerebral, frontal, or occipital cortices used. To establish whether levels of VMAT2 are in fact low in these cortical areas, we measured VMAT2 protein distribution by quantitative immunoblotting in autopsied normal human brain (
<italic>n</italic>
=6). Four or five species of VMAT2 immunoreactivity (75, 55, 52, 45, 35 kDa) were detected, which were all markedly reduced in intensity in nigrostriatal regions of patients with parkinsonian conditions versus matched controls (
<italic>n</italic>
=9 to 10 each). Using the intact VMAT2 immunoreactivity, cerebellar and cerebral neocortices had levels of the transporter >100-fold lower than the VMAT2-rich striatum and with no significant differences among the cortical regions. We conclude that human cerebellar and cerebral cortices contain negligible VMAT2 protein versus the striatum and, in this respect, all satisfy a criterion for a useful reference region for VMAT2 imaging. The slightly lower PET signal for VMAT2 binding in occipital (the currently preferred reference region) versus cerebellar cortex might not therefore be explained by differences in VMAT2 protein itself but possibly by other imaging variables, for example, partial volume effects.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Japon</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Tong, Junchao" sort="Tong, Junchao" uniqKey="Tong J" first="Junchao" last="Tong">Junchao Tong</name>
</noRegion>
<name sortKey="Boileau, Isabelle" sort="Boileau, Isabelle" uniqKey="Boileau I" first="Isabelle" last="Boileau">Isabelle Boileau</name>
<name sortKey="Chang, Li Jan" sort="Chang, Li Jan" uniqKey="Chang L" first="Li-Jan" last="Chang">Li-Jan Chang</name>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J" last="Kish">Stephen J. Kish</name>
<name sortKey="Kish, Stephen J" sort="Kish, Stephen J" uniqKey="Kish S" first="Stephen J" last="Kish">Stephen J. Kish</name>
<name sortKey="Tong, Junchao" sort="Tong, Junchao" uniqKey="Tong J" first="Junchao" last="Tong">Junchao Tong</name>
<name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A" last="Wilson">Alan A. Wilson</name>
</country>
<country name="Japon">
<noRegion>
<name sortKey="Furukawa, Yoshiaki" sort="Furukawa, Yoshiaki" uniqKey="Furukawa Y" first="Yoshiaki" last="Furukawa">Yoshiaki Furukawa</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001685 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001685 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3208151
   |texte=   Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21522164" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022